Basic Information
RNALocate ID: RLID:11002465
RNA Symbol: hsa-miR-376c-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-376c-3p
RNA ID: miRBase:MIMAT0000720
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23382797
Tissue/Cell Line: Brain tissue
Method: Microarray
Description: We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002028 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11002464 Exosome Serum 18589210
RLID:11002466 Exosome Plasma 23663360
RLID:11002467 Microvesicle Follicular fluid 23666971
RLID-D:11000410 Microvesicle Fibroblasts|Mesenchymal stem cells|Urine
RLID-D:11001198 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-376c-3p Splenic marginal zone lymphoma MNDR-E-MI-46176
MNDR hsa-miR-376c-3p Multiple sclerosis chronic progressive MNDR-E-MI-46177
MNDR hsa-miR-376c-3p Oral squamous cell carcinoma MNDR-E-MI-46178
MNDR hsa-miR-376c-3p Medulloblastoma MNDR-E-MI-46179
MNDR hsa-miR-376c-3p High-grade serous ovarian carcinoma MNDR-E-MI-46180
MNDR hsa-miR-376c-3p Uterine corpus endometrial carcinoma MNDR-E-MI-46181
MNDR hsa-miR-376c-3p Lymphoma MNDR-E-MI-46182
MNDR hsa-miR-376c-3p Lymphoma non-hodgkin MNDR-E-MI-46183
MNDR hsa-miR-376c-3p Estrogen-receptor positive breast cancer MNDR-E-MI-46184
MNDR hsa-miR-376c-3p Estrogen-receptor negative breast cancer MNDR-E-MI-46185
MNDR hsa-miR-376c-3p Progesterone-receptor positive breast cancer MNDR-E-MI-46186
MNDR hsa-miR-376c-3p Progesterone-receptor negative breast cancer MNDR-E-MI-46187
MNDR hsa-miR-376c-3p Her2-receptor positive breast cancer MNDR-E-MI-46188
MNDR hsa-miR-376c-3p Breast cancer luminal MNDR-E-MI-46189
MNDR hsa-miR-376c-3p Autosomal recessive limb-girdle muscular dystrophy type 2a MNDR-E-MI-46190
MNDR hsa-miR-376c-3p Dermatomyositis MNDR-E-MI-46191
MNDR hsa-miR-376c-3p Prostate cancer MNDR-E-MI-46192
MNDR hsa-miR-376c-3p Gastric cancer MNDR-E-MI-46193
MNDR hsa-miR-376c-3p Gastric lymphoma MNDR-E-MI-46194
MNDR hsa-miR-376c-3p Alzheimer disease MNDR-E-MI-46195
MNDR hsa-miR-376c-3p Bladder cancer MNDR-E-MI-46196
MNDR hsa-miR-376c-3p Dysautonomia familial MNDR-E-MI-46197
MNDR hsa-miR-376c-3p Distal muscular dystrophy MNDR-E-MI-46198
MNDR hsa-miR-376c-3p Duchenne muscular dystrophy MNDR-E-MI-46199
MNDR hsa-miR-376c-3p Facioscapulohumeral muscular dystrophy MNDR-E-MI-46200
MNDR hsa-miR-376c-3p Head and neck cancer MNDR-E-MI-46201
MNDR hsa-miR-376c-3p Cardiovascular disease MNDR-E-MI-46202
MNDR hsa-miR-376c-3p Parkinson disease MNDR-E-MI-46203
MNDR hsa-miR-376c-3p Basal-like breast cancer MNDR-E-MI-46204
MNDR hsa-miR-376c-3p Thyroid cancer MNDR-E-MI-46205
MNDR hsa-miR-376c-3p Pituitary neoplasms MNDR-E-MI-46206
MNDR hsa-miR-376c-3p Pancreatic cancer MNDR-E-MI-46207
MNDR hsa-miR-376c-3p Melanoma MNDR-E-MI-46208
MNDR hsa-miR-376c-3p Colon cancer MNDR-E-MI-46209
MNDR hsa-miR-376c-3p Colon adenocarcinoma MNDR-E-MI-46210
MNDR hsa-miR-376c-3p Ovarian cancer MNDR-E-MI-46211
MNDR hsa-miR-376c-3p Prostate adenocarcinoma MNDR-E-MI-46212
MNDR hsa-miR-376c-3p Carcinoma ductal breast MNDR-E-MI-46213
MNDR hsa-miR-376c-3p Glioblastoma MNDR-E-MI-46214
MNDR hsa-miR-376c-3p Glioma MNDR-E-MI-46215
MNDR hsa-miR-376c-3p Nemaline myopathy MNDR-E-MI-46216
MNDR hsa-miR-376c-3p Epilepsy temporal lobe MNDR-E-MI-46217
MNDR hsa-miR-376c-3p Osteosarcoma MNDR-E-MI-46218
MNDR hsa-miR-376c-3p Breast carcinoma MNDR-E-MI-46219
MNDR hsa-miR-376c-3p Meningioma MNDR-E-MI-46220
MNDR hsa-miR-376c-3p Gastric adenocarcinoma MNDR-E-MI-46221
MNDR hsa-miR-376c-3p Cervical squamous cell carcinoma MNDR-E-MI-46222
MNDR hsa-miR-376c-3p Bone-invasive pituitary adenoma MNDR-E-MI-46223
MNDR hsa-miR-376c-3p Lung adenocarcinoma MNDR-E-MI-46224
MNDR hsa-miR-376c-3p Adrenocortical cancer MNDR-E-MI-46225
MNDR hsa-miR-376c-3p Thyroid carcinoma MNDR-E-MI-46226
MNDR hsa-miR-376c-3p Ovarian carcinoma MNDR-E-MI-46227
MNDR hsa-miR-376c-3p Bladder urothelial carcinoma MNDR-E-MI-46228
MNDR hsa-miR-376c-3p Pancreatic adenocarcinoma MNDR-E-MI-46229
MNDR hsa-miR-376c-3p Carcinoma renal cell MNDR-E-MI-46230
MNDR hsa-miR-376c-3p Kidney renal papillary cell carcinoma MNDR-E-MI-46231
MNDR hsa-miR-376c-3p Renal clear cell carcinoma MNDR-E-MI-46232
MNDR hsa-miR-376c-3p Cholangiocarcinoma MNDR-E-MI-46233
MNDR hsa-miR-376c-3p Esophageal cancer MNDR-E-MI-46234
MNDR hsa-miR-376c-3p Lung small cell carcinoma MNDR-E-MI-46235
MNDR hsa-miR-376c-3p Synovial sarcoma MNDR-E-MI-46236
MNDR hsa-miR-376c-3p Head and neck squamous cell carcinoma MNDR-E-MI-46237
MNDR hsa-miR-376c-3p Breast invasive carcinoma MNDR-E-MI-46238
MNDR hsa-miR-376c-3p Hepatocellular carcinoma MNDR-E-MI-46239
MNDR hsa-miR-376c-3p B-cell lymphoma MNDR-E-MI-46240
MNDR hsa-miR-376c-3p Rheumatoid arthritis MNDR-E-MI-46241
MNDR hsa-miR-376c-3p T-cell leukemia MNDR-E-MI-46242
MNDR hsa-miR-376c-3p Barrett's adenocarcinoma MNDR-E-MI-46243
MNDR hsa-miR-376c-3p Hodgkin lymphoma MNDR-E-MI-46244
MNDR hsa-miR-376c-3p Burkitt lymphoma MNDR-E-MI-46245
MNDR hsa-miR-376c-3p Crohn disease MNDR-E-MI-46246
MNDR hsa-miR-376c-3p Tonsil cancer MNDR-E-MI-46247
MNDR hsa-miR-376c-3p Colorectal cancer MNDR-E-MI-46248
MNDR hsa-miR-376c-3p Multiple myeloma MNDR-E-MI-46249
MNDR hsa-miR-376c-3p Ovarian epithelial cancer MNDR-E-MI-46250
MNDR hsa-miR-376c-3p Subarachnoid hemorrhage traumatic MNDR-E-MI-46251
MNDR hsa-miR-376c-3p Stroke lacunar MNDR-E-MI-46252
MNDR hsa-miR-376c-3p Barrett's carcinogenesis MNDR-E-MI-46253
MNDR hsa-miR-376c-3p Breast cancer her3+ negative MNDR-E-MI-46254
MNDR hsa-miR-376c-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-46255
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ACVR1C Homo sapiens RR00039085
TOP